文献速递关节外科

收肌管阻滞与关节周围布比卡因注射在全膝关节置换术中的比较:一项前瞻性随机试验

Adductor Canal Block Compared with Periarticular Bupivacaine Injection for Total Knee Arthroplasty: A Prospective Randomized Trial.
PubMed 文献 · J Bone Joint Surg Am · 2018-01-01

155例在脊髓麻醉下接受初次全膝关节置换术的患者随机分为收肌管阻滞(ACB)单用组、关节周围注射(PAI)单用组及ACB+PAI组。ACB单用组术后第1天和第3天VAS疼痛评分显著高于ACB+PAI组,至术后第3天阿片类药物消耗量显著高于PAI单用组和ACB+PAI组;PAI单用组与ACB+PAI组在疼痛或阿片类药物消耗方面无显著差异。

要点

  • ACB单用组术后第1天VAS评分3.9 vs ACB+PAI组3.0(p=0.04),第3天4.2 vs 2.0(p=0.02)。
  • 至术后第3天总阿片消耗量ACB单用组131 ME vs PAI单用组100 ME(p=0.02)、vs ACB+PAI组98 ME(p=0.02)。
  • 术后第0天物理治疗活动水平ACB单用组26步 vs PAI单用组68步(p<0.001)、vs ACB+PAI组65步(p<0.001)。

核心结论

  • 该随机对照临床试验表明,全膝关节置换术中使用ACB而不使用PAI与更高的疼痛评分和阿片类药物消耗相关,提示ACB单用在围手术期疼痛控制方面较差。
  • PAI单用与ACB+PAI在疼痛或阿片类药物消耗方面无显著差异。

研究设计与样本

  • 前瞻性随机试验,纳入155例在脊髓麻醉下接受初次全膝关节置换术的患者,随机分为3组:ACB单用组(15 mL 0.5%布比卡因)、PAI单用组(50 mL 0.25%布比卡因加肾上腺素)和ACB+PAI组,主要结局为术后即刻视觉模拟量表(VAS)疼痛评分。

主要发现

  • ACB单用组平均VAS疼痛评分在术后第1天(3.9 vs 3.0,p=0.04)和术后第3天(4.2 vs 2.0,p=0.02)显著高于ACB+PAI组。
  • 至术后第3天总阿片类药物消耗量ACB单用组为131吗啡当量(ME),显著高于PAI单用组的100 ME(p=0.02)和ACB+PAI组的98 ME(p=0.02)。
  • ACB单用组阿片类药物消耗量在术后第2天和第3天显著高于ACB+PAI组,在术后第2天显著高于PAI单用组。
  • PAI单用组与ACB+PAI组之间阿片类药物消耗量无显著差异。
  • 术后第0天物理治疗活动水平ACB单用组为26步,显著低于PAI单用组的68步(p<0.001)和ACB+PAI组的65步(p<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In the last decade, the widespread use of regional anesthesia in total knee arthroplasty has led to improvements in pain control, more rapid functional recovery, and reductions in the length of the hospital stay. The aim of this study was to compare the efficacy of adductor canal blocks (ACB) and periarticular anesthetic injections (PAI), both with bupivacaine, for pain management in total knee arthroplasty. METHODS: One hundred and fifty-five patients undergoing primary total knee arthroplasty under spinal anesthesia were randomized to 1 of 3 groups: ACB alone (15 mL of 0.5% bupivacaine), PAI alone (50 mL of 0.25% bupivacaine with epinephrine), and ACB+PAI. The primary outcome in this study was the visual analog scale (VAS) pain score in the immediate postoperative period. Secondary outcomes included postoperative opioid use, activity level during physical therapy, length of hospital stay, and knee range of motion. RESULTS: The mean VAS pain score was significantly higher after use of ACB alone, compared with the score after use of ACB+PAI, on postoperative day 1 (POD1) (3.9 versus 3.0, p = 0.04) and POD3 (4.2 versus 2.0, p = 0.02). Total opioid consumption through POD3 was significantly higher when ACB alone had been used (131 morphine equivalents [ME]) compared with PAI alone (100 ME, p = 0.02) and ACB+PAI (98 ME, p = 0.02). Opioid consumption in the ACB-alone group was significantly higher than that in the ACB+PAI group on POD2 and POD3 and significantly higher than that in the PAI-alone group on POD2. There was no significant difference in opioid consumption between the patients treated with PAI alone and those who received ACB+PAI. The activity level during physical therapy on POD0 was significantly lower after use of ACB alone (26 steps) than after use of PAI alone (68 steps, p < 0.001) or ACB+PAI (65 steps, p < 0.001). CONCLUSIONS: This randomized controlled clinical trial demonstrated significantly higher pain scores and opioid consumption after total knee arthroplasty done with an ACB and without PAI, suggesting that ACB alone is inferior for perioperative pain control. There were no significant differences between PAI alone and ACB+PAI with regard to pain or opioid consumption. LEVEL OF EVIDENCE: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Grosso MJ, Murtaugh T, Lakra A, et al. Adductor Canal Block Compared with Periarticular Bupivacaine Injection for Total Knee Arthroplasty: A Prospective Randomized Trial. J Bone Joint Surg Am. 2018. PMID: 29975272. doi:10.2106/JBJS.17.01177

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。